Clinical and pharmacogenetic data used to estimate warfarin dosing

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:519 / 519
页数:1
相关论文
共 50 条
  • [41] Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials
    Li, Xiaoqi
    Yang, Jie
    Wang, Xuyun
    Xu, Qiang
    Zhang, Yuxiao
    Yin, Tong
    [J]. THROMBOSIS RESEARCH, 2015, 135 (04) : 621 - 629
  • [42] Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial
    Anand, Aishwarya
    Hegde, Naveen C.
    Chhabra, Pulkit
    Purohit, Jai
    Kumar, Rupesh
    Gupta, Ankur
    Lad, Deepesh P.
    Mohindra, Ritin
    Mehrotra, Saurabh
    Vijayvergiya, Rajesh
    Kumar, Basant
    Sharma, Vishal
    Malhotra, Pankaj
    Ahluwalia, Jasmina
    Das, Reena
    Patil, Amol N.
    Shafiq, Nusrat
    Malhotra, Samir
    [J]. ANNALS OF HEMATOLOGY, 2024, 103 (06) : 2133 - 2144
  • [43] Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
    Liu, Rong
    Li, Xi
    Zhang, Wei
    Zhou, Hong-Hao
    [J]. PLOS ONE, 2015, 10 (08):
  • [44] Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
    Verhoef, Talitha I.
    Redekop, William K.
    Daly, Ann K.
    van Schie, Rianne M. F.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) : 626 - 641
  • [45] Cost-Effectiveness Analysis of Pharmacogenetic-Guided Warfarin Dosing in Thailand
    Chong, Huey Yi
    Saokaew, Surasak
    Dumrongprat, Kuntika
    Permsuwan, Unchalee
    Wu, David Bin-Chia
    Sritara, Piyamitr
    Chaiyakunapruk, Nathorn
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 : S2 - S2
  • [46] Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients
    Ramos, Alga S.
    Seip, Richard L.
    Rivera-Miranda, Giselle
    Felici-Giovanini, Marcos E.
    Garcia-Berdecia, Rafael
    Alejandro-Cowan, Yirelia
    Kocherla, Mohan
    Cruz, Iadelisse
    Feliu, Juan F.
    Cadilla, Carmed L.
    Renta, Jessica Y.
    Gorowski, Krystyna
    Vergara, Cunegundo
    Ruano, Gualberto
    Duconge, Jorge
    [J]. PHARMACOGENOMICS, 2012, 13 (16) : 1937 - 1950
  • [47] COUNTERPOINT - Pharmacogenetic-Based Initial Dosing of Warfarin: Not Ready for Prime Time
    Eby, Charles S.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (04) : 712 - 714
  • [48] The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin
    Andrej Janzic
    Igor Locatelli
    Mitja Kos
    [J]. American Journal of Cardiovascular Drugs, 2017, 17 : 399 - 408
  • [49] The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin
    Janzic, Andrej
    Locatelli, Igor
    Kos, Mitja
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (05) : 399 - 408